Study S002042
Effect of a Progressive Resistance Exercise Program on Muscle Mass and Physical Function During a Tirzepatide Induced Weight Loss in Overweight and Obese Females: a Randomised Parallel Group Study
Registration
Registered primary outcomes
- Skeletal Muscle Mass [Skeletal muscle mass will be plotted over time and we will compare the pre , mid and post values (weeks 0, 10 and 20) to see if there was a change in both groups.]
- Muscle Thickness (Ultrasound) [Muscle thickness in millimetres will be plotted over time (week 0, 4, 8, 10, 12, 16, 20) and compared between the two groups. Muscle thickness will also be measure at two separate time points during a follow up study at week 40 and 72 weeks from week 0.]
Linked records (3)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
| Record | Title | Year | Design | Identifiers | Link basis |
|---|---|---|---|---|---|
| R0017139 | Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Look M, Diabetes, obesity & metabolism | 2025 | Other trial | PMID 39996356DOI | registry reference BACKGROUND:39996356 |
| R0010987 | Tirzepatide Once Weekly for the Treatment of Obesity. Jastreboff AM, The New England journal of medicine | 2022 | Randomized trial | PMID 35658024DOI | registry reference BACKGROUND:35658024 |
| R0008567 | A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans. Sargeant JA, Endocrinology and metabolism (Seoul, Korea) | 2019 | Narrative review | PMID 31565876DOI | registry reference BACKGROUND:31565876 |